193 related articles for article (PubMed ID: 31392938)
1. Expression of BTK/p-BTK is different between CD5
Duan N; Zhao M; Wang Y; Qu Y; Liu H; Wang H; Xing L; Shao Z
Hematology; 2019 Dec; 24(1):588-595. PubMed ID: 31392938
[No Abstract] [Full Text] [Related]
2. CD5
Zhao M; Duan N; Wang Y; Zhu H; Liu H; Wang H; Xing L; Shao Z
Autoimmunity; 2019 Feb; 52(1):12-20. PubMed ID: 30784322
[TBL] [Abstract][Full Text] [Related]
3. Expression of activated molecules on CD5(+)B lymphocytes in autoimmune hemolytic anemia.
Zhu H; Xu W; Liu H; Wang H; Fu R; Wu Y; Qu W; Wang G; Guan J; Song J; Xing L; Shao Z
Int J Hematol; 2016 May; 103(5):545-53. PubMed ID: 26968550
[TBL] [Abstract][Full Text] [Related]
4. [The clinical significance of CD(4)(+)CD(69)(+) T lymphocytes in patients with autoimmune hemolytic anemia/Evans syndrome].
Xing LM; Xu WY; Duan NN; Qu YY; Liu ZY; Shao ZH
Zhonghua Nei Ke Za Zhi; 2018 Sep; 57(9):656-660. PubMed ID: 30180450
[No Abstract] [Full Text] [Related]
5. Subtypes of B lymphocytes in patients with autoimmune hemocytopenia.
Xing LM; Shao ZH; Fu R; Liu H; Shi J; Bai J; Tu MF; Wang HQ; Cui ZZ; Jia HR; Sun J; Yang CL
Chin Med Sci J; 2007 Jun; 22(2):128-31. PubMed ID: 17763587
[TBL] [Abstract][Full Text] [Related]
6. B cells CD19+ in patients with B-cell chronic lymphocytic leukaemia and autoimmune haemolytic anaemia.
Słomkowski M; Kopeć-Szlezak J; Fabijańska-Mitek J; Podstawka U; Sikorska A; Mendek-Czajkowska E
Clin Lab Haematol; 2004 Dec; 26(6):385-9. PubMed ID: 15595995
[TBL] [Abstract][Full Text] [Related]
7. miR-150 regulates B lymphocyte in autoimmune hemolytic anemia/Evans syndrome by c-Myb.
Xing L; Xu W; Qu Y; Zhao M; Zhu H; Liu H; Wang H; Su X; Shao Z
Int J Hematol; 2018 Jun; 107(6):666-672. PubMed ID: 29488168
[TBL] [Abstract][Full Text] [Related]
8. A case of chronic lymphocytic leukemia complicated by autoimmune hemolytic anemia due to ibrutinib treatment.
Suzuki T; Miyakoshi S; Nanba A; Uchiyama T; Kawamoto K; Aoki S
J Clin Exp Hematop; 2018 Sep; 58(3):136-140. PubMed ID: 30012921
[TBL] [Abstract][Full Text] [Related]
9. The pathologic significance of the immunoglobulins expressed by chronic lymphocytic leukemia B-cells in the development of autoimmune hemolytic anemia.
Efremov DG; Ivanovski M; Burrone OR
Leuk Lymphoma; 1998 Jan; 28(3-4):285-93. PubMed ID: 9517500
[TBL] [Abstract][Full Text] [Related]
10. Role of Bruton's tyrosine kinase in B cells and malignancies.
Pal Singh S; Dammeijer F; Hendriks RW
Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
[TBL] [Abstract][Full Text] [Related]
11. BTK Inhibitors in Haematology: Beyond B Cell Malignancies.
Leitinger DE; Kaplan DZ
Transfus Med Rev; 2022 Oct; 36(4):239-245. PubMed ID: 36376164
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia.
Sthoeger ZM; Sthoeger D; Shtalrid M; Sigler E; Geltner D; Berrebi A
Am J Hematol; 1993 Aug; 43(4):259-64. PubMed ID: 7690517
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte activation and cytokine production in autoimmune hemolytic anaemia (AIHA).
Fagiolo E; Abenante L
Autoimmunity; 1996; 24(3):147-56. PubMed ID: 9020407
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of Bruton's tyrosine kinase in peripheral blood is associated with lupus nephritis.
Kong W; Deng W; Sun Y; Huang S; Zhang Z; Shi B; Chen W; Tang X; Yao G; Feng X; Sun L
Clin Rheumatol; 2018 Jan; 37(1):43-49. PubMed ID: 28612243
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 6 exacerbates the progression of warm autoimmune hemolytic anemia by influencing the activity and function of B cells.
Zhao M; Chen L; Yang J; Zhang Z; Wang H; Shao Z; Liu X; Xing L
Sci Rep; 2023 Aug; 13(1):13231. PubMed ID: 37580421
[TBL] [Abstract][Full Text] [Related]
16. The clinical characteristics of autoimmune haemolytic anaemia/Evans syndrome patients with clonal immunoglobulin/T cell receptor gene rearrangement.
Zhu H; Zhao M; Cao Z; Yang J; Li Y; Xing L
Autoimmunity; 2020 Nov; 53(7):394-399. PubMed ID: 32924630
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune hemolytic anemia (AIHA) associated with chronic lymphocytic leukemia in the current era of targeted therapy.
Molica S; Polliack A
Leuk Res; 2016 Nov; 50():31-36. PubMed ID: 27657651
[TBL] [Abstract][Full Text] [Related]
18. A high rate of CLL phenotype lymphocytes in autoimmune hemolytic anemia and immune thrombocytopenic purpura.
Mittal S; Blaylock MG; Culligan DJ; Barker RN; Vickers MA
Haematologica; 2008 Jan; 93(1):151-2. PubMed ID: 18166805
[TBL] [Abstract][Full Text] [Related]
19. Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome.
Carli G; Visco C; Falisi E; Perbellini O; Novella E; Giaretta I; Ferrarini I; Sandini A; Alghisi A; Ambrosetti A; Rodeghiero F
Ann Hematol; 2016 May; 95(6):863-70. PubMed ID: 27001309
[TBL] [Abstract][Full Text] [Related]
20. Evidence for enhanced Bruton's tyrosine kinase activity in transitional and naïve B cells of patients with granulomatosis with polyangiitis.
von Borstel A; Abdulahad WH; Sanders JS; Rip J; Neys SFH; Hendriks RW; Stegeman CA; Heeringa P; Rutgers A; Corneth OBJ
Rheumatology (Oxford); 2019 Dec; 58(12):2230-2239. PubMed ID: 31209475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
